Search Results - "Constenla, M"

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer by Rosell, R., Robinet, G., Szczesna, A., Ramlau, R., Constenla, M., Mennecier, B. C., Pfeifer, W., O'Byrne, K. J., Welte, T., Kolb, R., Pirker, R., Chemaissani, A., Perol, M., Ranson, M. R., Ellis, P. A., Pilz, K., Reck, M.

“…Background: The Lung Cancer Cetuximab Study is an open-label, randomized phase II pilot study of cisplatin and vinorelbine combined with the epidermal growth…”
Get full text

Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS by Arriola, E., Paredes-Lario, A., García-Gomez, R., Diz-Tain, P., Constenla, M., García-Girón, C., Márquez, G., Reck, M., López-Vivanco, G.

“…Purpose The analysis of epidermal growth factor receptor ( EGFR ) mutations in many patients with advanced non-small-cell lung cancer (aNSCLC) has provided the…”
Get full text

Endolimax piscium sp. nov. (Amoebozoa), causative agent of systemic granulomatous disease of cultured sole, Solea senegalensis Kaup by Constenla, M, Padrós, F, Palenzuela, O

“…A new amoeba species pathogenic for Senegalese sole is described based on ultrastructural analysis and SSU rDNA phylogenetic inference. The parasite presents…”
Get full text

Horizontal transmission of Endolimax piscium, causative agent of systemic amoebiasis in Senegalese sole Solea senegalensis by Constenla, M, Padrós, F, Villanueva-González, A, Del Pozo, R, Palenzuela, O

“…Systemic amoebiasis of Senegalese sole Solea senegalensis is caused by Endolimax piscium Constenla, Padrós & Palenzuela, 2014 a cryptic parasitic member of the…”
Get full text

Description and molecular analysis of an Italian population of Centrorhynchus globo caudatus (Zeder, 1800) Lühe, 1911 (Acanthocephala: Centrorhynchidae) from Falco tinnunculus (Falconidae) and Buteo buteo (Accipitridae) by Amin, O M, Heckmann, R A, Dallarés, S, Constenla, M, Rubini, S

“…Centrorhynchus globocaudatus (Zeder, 1800) Lühe, 1911 (Centrorhynchidae) was reported in birds of prey. Our population from Falco tinnunculus Linnaeus…”
Get more information

Is there any affordable and reliable score in local gastric cancer? by Cousillas Castiñeiras, A., Gallardo Martin, E., Fernández Montes, A., Covela Rúa, M., Carmona Campos, M., Salgado Fernandez, M., Pellón Augusto, M., Vidal Insua, Y., Gonzalez Villarroel, P., Martínez-Lago, N., De la Cámara Gómez, J., Candamio Folgar, S., Brozos Vázquez, E., Fernandez, M. Jorge, Vázquez Rivera, F., Méndez Méndez, J., Quintero Aldana, G., Constenla, M.

Get full text

Development of different diagnostic techniques for Endolimax piscium (archamoebae) and their applicability in Solea senegalensis clinical samples by Constenla, M, Padrós, F, del Pozo, R, Palenzuela, O

“…Systemic amoebiasis of sole is caused by Endolimax piscium, a cryptic parasitic archamoeba whose epidemiology and pathogeny are yet unknown. To establish…”
Get full text

Annual variation of parasite communities of deep-sea macrourid fishes from the western Mediterranean Sea and their relationship with fish diet and histopathological alterations by Constenla, M., Montero, F.E., Padrós, F., Cartes, J.E., Papiol, V., Carrassón, M.

“…Parasite communities of three abundant benthopelagic macrourid species (Hymenocephalus italicus, Nezumia aequalis and Trachyrincus scabrus) of the upper slope…”
Get full text

Parasite communities of the deep-sea fish Alepocephalus rostratus Risso, 1820 in the Balearic Sea (NW Mediterranean) along the slope and relationships with enzymatic biomarkers and health indicators by Pérez-i-García, D., Constenla, M., Padrós, F., Soler-Membrives, A., Solé, M., Carrassón, M.

“…This study examines the parasite communities of Alepocephalus rostratus and its influence on some fish biochemical markers and histological alterations. A…”
Get full text

BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study by Barnadas, A., Muñoz, M., Margelí, M., Chacón, J. I., Cassinello, J., Antolin, S., Adrover, E., Ramos, M., Carrasco, E., Jimeno, M. A., Ojeda, B., González, X., González, S., Constenla, M., Florián, J., Miguel, A., Llombart, A., Lluch, A., Ruiz-Borrego, M., Colomer, R., Del Barco, S.

“…Background Bone metastasis (BM) is the most common site of disease in metastatic breast cancer (MBC) patients. BM impacts health-related quality of life…”
Get full text

Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention by Cueva, J. F., Antolín, S., Calvo, L., Fernández, I., Ramos, M., de Paz, L., Mata, J. G., López, R., Constenla, M., Pérez, E., González, A., Pellón, M. L., Varela, S., López, T.

“…This Galician consensus statement is a joint oncologists/cardiologists initiative indented to establish basic recommendations on how to prevent and to manage…”
Get full text

A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy by León, X., Hitt, R., Constenla, M., Rocca, A., Stupp, R., Kovács, A.F., Amellal, N., Bessa, E.H., Bourhis, J.

“…Recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) develops in around 72 000 people in Europe every year. Treatment options are…”
Get full text

Histopathological and ultrastructural studies on a novel pathological condition in Solea senegalensis by CONSTENLA, M, PADROS, F

“…A new parasitic disease affecting cultured sole Solea senegalensis (Kaup, 1858) is characterised by the presence of external protuberances in the skin of the…”
Get full text

Parasitisation by Bathycreadium elongatum (Digenea, Opecoelidae) in pyloric caeca of Trachyrincus scabrus (Teleostei, Macrouridae) by CONSTENLA, M, CARRASSON, M, MOYA, C. M, FERNANDEZ-CHACON, A, PADROS, F, REPULLES-ALBELDA, A, MONTERO, F. E

“…A novel process of transmural passive displacement of a digenean parasite was studied in the digestive tract of the roughsnout grenadier Trachyrincus scabrus,…”
Get full text

5-HT3 Receptor Antagonists for Prevention of Late Acute-Onset Emesis by Constenla, Manuel

“…OBJECTIVE To review the currently available literature on the efficacy of the 5–HT3 receptor antagonists in the prevention of late acute-onset…”
Get full text

Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: A randomized phase 2 trial by Romieu, G, Clemens, M, Mahlberg, R, Fargeot, P, Constenla, M, Schütte, M, Easton, V, Skacel, T, Bacon, P, Brugger, W

“…Abstract This randomized phase 2 study explored the feasibility of delivering four to six cycles of the dose-intensified regimen FEC-100 (5-fluorouracil,…”
Get full text

P76 Incidence of febrile neutropenia, chemotherapy delivery and use of colony-stimulating factor in NHL patients of different age groups by Pettengell, R, Constenla, M, Schwenkglenks, M

Get full text

Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study by Aranda, E., Valladares, M., Martinez-Villacampa, M., Benavides, M., Gomez, A., Massutti, B., Marcuello, E., Constenla, M., Cámara, J. C., Carrato, A., Dueñas, R., Reboredo, M., Navarro, M., Díaz-Rubio, E.

“…Background: Irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI) is accepted as a reference treatment for the first-line treatment of patients with…”
Get full text

Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer by Carrato, A., Gómez, A., Escudero, P., Chaves, M., Rivera, F., Marcuello, E., González, E., Grávalos, C., Constenla, M., Manzano, J. Luis, Losa, F., Maurel, J., Dueñas, R., Massuti, B., Gallego, J., Aparicio, J., Antón, A., Aranda, E.

“…Purpose To evaluate the efficacy and safety profile of the combination of panitumumab and irinotecan every 3 weeks in a phase II trial as second-line treatment…”
Get full text

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced metastatic breast cancer by BATISTA, N, PEREZ-MANGA, G, CASINELLO, J, REGUEIRO, P, MURIAS, A, CONSTENLA, M, RUIZ, A, CARABANTES, F, CASTELLANOS, J, GONZALEZ BARON, M, VILLMAN, K, SÖDERBERG, M, AHLGREN, J

“…The addition of oral capecitabine to docetaxel improves response rate, time to progression (TTP) and overall survival in anthracycline-pretreated metastatic…”
Get full text